cambridge's bluebird bio licenses delivery tech to novartis, gsk.
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before..
.
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before..
.